Thalidomide
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13557 publications
Targeted degradation of xanthine oxidase via PROTAC technology for the treatment of hyperuricaemia.
Journal: Journal of materials chemistry. B
Published: April 14, 2026
A new therapeutic approach for Parkinson's disease: dual targeting of α-Synuclein aggregation and microglial function by the novel immunomodulator 3-Monothiopomalidomide.
Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026
Degradation of the TEAD·YAP/TAZ Transcription Factor Complex by Heterobifunctional Small Molecules That Bind to the TEAD Allosteric Lipid Pocket.
Journal: ACS chemical biology
Published: April 08, 2026
The neuroprotective effects of thalidomide in cerebral ischemia-reperfusion injury induced by bilateral carotid artery occlusion in rats.
Journal: Biotechnic & histochemistry : official publication of the Biological Stain Commission
Published: April 02, 2026
Targeting CRBN With Thalidomide Suppresses Fibrosis After Glaucoma Drainage Surgery Through NF-κB Pathway Inhibition.
Journal: Investigative ophthalmology & visual science
Published: March 20, 2026
Early intervention for high-risk smoldering multiple myeloma (SMM).
Journal: The Cochrane database of systematic reviews
Published: March 18, 2026
Retraction notice to "The effect of enantiomers of thalidomide on colon cells-Raman spectroscopy studies" [Spectrochim. Acta Part A: Mol. Biomol. Spectrosc. 341 (2025) 126423].
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Published: March 14, 2026
Efficacy and Safety of Thalidomide for the Treatment of Minor Recurrent Aphthous Stomatitis: A Systematic Review.
Journal: The journal of contemporary dental practice
Published: March 13, 2026
Current and emerging pharmacotherapies for treating vascular malformations.
Journal: Expert review of clinical pharmacology
Published: March 08, 2026
A Cross-sectional Exploratory Study on Symptom Correlations in Multiple Myeloma Patients During Initial Treatment Using the Edmonton Symptom Assessment System.
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Published: March 01, 2026
Diagnosis and treatment of digestive angiodysplasias
Journal: La Revue du praticien
Published: February 24, 2026
On-label persistence in psoriasis after switching to guselkumab, tumor necrosis factor inhibitors, interleukin-17 inhibitors, or apremilast from other advanced therapies.
Journal: The Journal of dermatological treatment
Published: February 24, 2026
Last Updated: 04/28/2026